Avitide Rolls Out Series A to Launch Biologics Purification Co.
This article was originally published in The Pink Sheet Daily
Executive Summary
Avitide Inc. raised an undisclosed Series A financing from a strong and familiar syndicate to provide custom affinity purification solutions to biologics manufacturers.
You may also be interested in...
Polaris Partners: The 2013 A-List Investor Spotlight
Polaris’ focus on people and platforms was never more evident than in 2013, when it leveraged its relationship with one entrepreneur in particular to great effect.
MorphoSys Finds Right Time To Focus On Pipeline With AbD Serotec Sale To Bio-Rad Labs
MorphoSys sells some of its assets in an effort to concentrate on its proprietary therapeutic endeavors – including a mid-stage rheumatoid arthritis drug.
Hijacking The Messenger
Recent excitement around exosomes underscores their potential to solve drug delivery challenges that have limited the power and applicability of the biopharma industry’s growing arsenal of therapeutic modalities.